Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies	non-small cell lung carcinoma	Recruiting	Phase 1 / Phase 2	2026-07-01		NCT05443126
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 3	2026-03-18		NCT06726265

Clinical trials